A Real-world Evidence on Effectiveness and Safety of Blinatumomab in Patients With B-cell Acute Lymphoblastic Leukaemia

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Disease registry

  Other
• Data sources (types), other:
  Prescription event monitoring, Case-control surveillance database

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.